Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Italy Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20053
20061
20074
20082
20092
20101
20113
20123
20133
20141
20151
20182
20191
20211
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Unknown status6
Active, not recruiting3
Terminated2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Novartis Pharmaceuticals3
Boston Scientific Corporation2
Marco Valgimigli2
University of Roma La Sapienza2
A.O. Ospedale Papa Giovanni XXIII1
Abbott Medical Devices1
Air Liquide Santé International1
Amgen1
Azienda Ospedaliera Universitaria Policlinico "G. Martino"1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease35
Acute Coronary Syndrome7
Myocardial Infarction5
Cardiovascular Diseases3
Diabetes Mellitus3
Diabetes Mellitus, Type 23
Heart Diseases3
Peripheral Arterial Disease3
Stroke3
Angina Pectoris2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.